0,1,2,3,4,5,6,7
Table 4. The predicted epitopes from E6 oncoproteins in the first step selection.,,,,,,,
Protein,Epitope,Location,Immunogenicity,Population,Proteasomal,TAP,Processing
,,(length),Score,Coverage,Cleavage score,score,score
HPV16-E6,FAFRDLCIVY,52–61 (10),0.19,83.26%,1.94,1.24,3.18
,IVYRDGNPY,59–67 (9),0.09,86.66%,1.13,1.42,2.55
,CYSLYGTTL,87–95 (9),0.02,99.94%,1.58,0.49,2.06
,VYDFAFRDL,49–57 (9),0.33,99.99%,1.35,0.41,1.75
,KFYSKISEY,75–83 (9),-0.33,99.57%,1.39,1.49,2.88
,SEYRHYCYSL,81–90 (10),-0.07,99.96%,1.59,0.47,2.25
,KLPQLCTEL,18–26 (9),-0.09,99.98%,1.41,0.52,1.93
,ISEYRHYCY,80–88 (9),0.08,24.94%,1.57,1.28,2.85
,EYRHYCYSL,82–90 (9),-0.11,99.91%,1.59,0.49,2.08
,YCYSLYGTTL,86–95 (10),-0.10,99.99%,1.58,0.49,2.06
HPV18-E6,KLPDLCTEL,13–21 (9),0.05,99.99%,1.65,0.44,2.09
,TVLELTEVF,37–45 (9),0.23,99.27%,1.43,1.20,2.63
,FAFKDLFVVY,47–56 (10),0.01,86.98%,1.90,1.23,3.12
,LELTEVFEF,39–47 (9),0.33,49.80%,1.40,1.07,2.47
,DFYSRIREL,70–78 (9),0.11,87.51%,1.64,0.44,2.08
,FEFAFKDLF,45–53 (9),0.01,75.51%,1.15,1.07,2.22
,FAFKDLFVV,47–55 (9),-0.05,96.60%,1.02,0.09,1.11
,AFKDLFVVY,48–56 (9),0.11,95.40%,1.90,1.36,3.25
,LQDIEITCVY,25–34 (10),0.38,51.48%,1.31,1.25,2.56
,SVYGDTLEK,84–92 (9),0.14,58.01%,0.94,0.31,1.24
HPV31-E6,FAFTDLTIVY,45–54 (10),0.26,93.1%,1.87,1.24,3.11
,RYSVYGTTL,80–88 (9),0.07,100.0%,1.48,0.61,2.09
,KVSEFRWYRY,72–81 (10),0.45,68.2%,1.43,1.40,2.83
,FRWYRYSVY,76–84 (9),0.00,66.2%,1.45,1.32,2.77
,YRYSVYGTTL,79–88 (10),-0.04,100.0%,1.48,0.55,2.03
,LSSALEIPY,15–23 (9),0.18,61.3%,1.00,1.21,2.22
,KVSEFRWYR,72–80 (9),0.40,99.9%,0.90,0.77,1.67
,AFTDLTIVY,46–54 (9),0.20,97.6%,1.87,1.34,3.21
,KLHELSSAL,11–19 (9),-0.17,99.96%,1.39,0.54,1.93
,FAFTDLTIV,45–53 (9),0.20,95.45%,1.03,0.11,1.13
HPV45-E6,IVYRDCIAY,54–62 (9),0.16,81.72%,1.55,1.42,2.97
,KLPDLCTEL,13–21 (9),0.05,99.99%,1.65,0.44,2.09
,YSRIRELRY,72–80 (9),0.32,85.96%,1.46,1.25,2.71
,ATLERTEVY,37–45 (9),0.29,97.51%,1.40,1.37,2.79
,FAFKDLCIVY,47–56 (10),-0.08,83.30%,1.90,1.28,3.15
,DFYSRIREL,70–78 (9),0.11,98.61%,1.56,0.44,1.99
,YQFAFKDL,45–52 (8),0.01,80.70%,1.44,0.51,1.95
,NPAEKRRHL,113–121 (9),0.02,45.86%,1.62,0.33,1.95
,RTEVYQFAF,41–49 (9),0.08,99.99%,1.49,1.06,2.55
,YSRIRELRYY,72–81 (10),0.33,80.75%,1.30,1.25,2.56
,https://doi.org/10.1371/journal.pone.0205933.t004,,,,,,
